What Is LH Fair Value?
Labcorp (LH) fair value estimate using multiple valuation models, updated daily.
As of October 14, 2026, Labcorp (LH) has a composite fair value estimate of $204.40 based on four valuation models: DCF (35% weight), Graham Number (25% weight), PEG (25% weight), and DDM (15% weight). The current market price is $313.64, suggesting the stock is overvalued by 34.8%.
Data as of October 14, 2026 (today)
Composite Fair Value
Overvalued4 of 4 models$204.40
vs. current price of $313.64(-34.8%)
How Is LH Fair Value Calculated?
Four independent models estimate what LH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
LH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
35% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$232.23
-26.0%Overvalued
Inputs used
DDM (Dividend Discount Model)
15% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$70.09
-77.7%Overvalued
Inputs used
LH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
25% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
$209.58
-33.2%Overvalued
Inputs used
PEG (Price/Earnings to Growth)
25% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$183.49
-41.5%Overvalued
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $313.64 is 26.0% above this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $978.5M | $905.6M |
| Year 2 | $1.07B | $919.3M |
| Year 3 | $1.18B | $933.2M |
| Year 4 | $1.29B | $947.4M |
| Year 5 | $1.42B | $961.7M |
| Year 6 | $1.55B | $976.3M |
| Year 7 | $1.70B | $991.1M |
| Year 8 | $1.87B | $1.01B |
| Year 9 | $2.05B | $1.02B |
| Year 10 | $2.25B | $1.04B |
| Terminal Value | $41.52B | $19.14B |
What Are LH's Key Financial Metrics?
Earnings & Growth
Current Price
$313.64
EPS (TTM)
$12.09
Forward P/E
15.9
Profit Margin
7.0%
Cash & Balance Sheet
Free Cash Flow
892M
EBITDA
2.3B
Book Value
$106.39
Total Debt
6.8B
What Do Analysts Say About LH?
Low
$293.00
Average
$345.13
High
$385.00
Upside
+10.0%
LH Fair Value FAQ
What is the fair value of LH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), LH's estimated fair value is $204.40. The stock is currently trading at $313.64, which makes it overvalued by our analysis.
How is LH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is LH overvalued or undervalued?
Based on our analysis, LH is overvalued. The current price of $313.64 is 34.8% above our estimated fair value of $204.40.
What do Wall Street analysts say about LH?
16 analysts cover Labcorp with a consensus rating of "Buy." The average price target is $345.13, ranging from $293.00 to $385.00. This implies 10.0% upside from the current price.